| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-12 00:06:41 UTC |
|---|
| Update Date | 2021-09-26 23:18:17 UTC |
|---|
| HMDB ID | HMDB0260257 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)- |
|---|
| Description | 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)-, also known as 4-(2H-1,3-benzodioxol-5-yl)-1-{[(2,6-diethylphenyl)-C-hydroxycarbonimidoyl]methyl}-2-(4-propoxyphenyl)pyrrolidine-3-carboxylate, belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids. Based on a literature review very few articles have been published on 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)-. This compound has been identified in human blood as reported by (PMID: 31557052 ). 3-pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2r,3r,4s)- is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)- is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CCCOC1=CC=C(C=C1)C1C(C(CN1CC(=O)NC1=C(CC)C=CC=C1CC)C1=CC2=C(OCO2)C=C1)C(O)=O InChI=1S/C33H38N2O6/c1-4-16-39-25-13-10-23(11-14-25)32-30(33(37)38)26(24-12-15-27-28(17-24)41-20-40-27)18-35(32)19-29(36)34-31-21(5-2)8-7-9-22(31)6-3/h7-15,17,26,30,32H,4-6,16,18-20H2,1-3H3,(H,34,36)(H,37,38) |
|---|
| Synonyms | | Value | Source |
|---|
| 4-(2H-1,3-Benzodioxol-5-yl)-1-{[(2,6-diethylphenyl)-C-hydroxycarbonimidoyl]methyl}-2-(4-propoxyphenyl)pyrrolidine-3-carboxylate | HMDB |
|
|---|
| Chemical Formula | C33H38N2O6 |
|---|
| Average Molecular Weight | 558.675 |
|---|
| Monoisotopic Molecular Weight | 558.272986952 |
|---|
| IUPAC Name | 4-(2H-1,3-benzodioxol-5-yl)-1-{[(2,6-diethylphenyl)carbamoyl]methyl}-2-(4-propoxyphenyl)pyrrolidine-3-carboxylic acid |
|---|
| Traditional Name | 4-(2H-1,3-benzodioxol-5-yl)-1-{[(2,6-diethylphenyl)carbamoyl]methyl}-2-(4-propoxyphenyl)pyrrolidine-3-carboxylic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCCOC1=CC=C(C=C1)C1C(C(CN1CC(=O)NC1=C(CC)C=CC=C1CC)C1=CC2=C(OCO2)C=C1)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C33H38N2O6/c1-4-16-39-25-13-10-23(11-14-25)32-30(33(37)38)26(24-12-15-27-28(17-24)41-20-40-27)18-35(32)19-29(36)34-31-21(5-2)8-7-9-22(31)6-3/h7-15,17,26,30,32H,4-6,16,18-20H2,1-3H3,(H,34,36)(H,37,38) |
|---|
| InChI Key | LQEHCKYYIXQEBM-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Alpha amino acid amides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha-amino acid amide
- 2-phenylpyrrolidine
- Benzodioxole
- Anilide
- Phenoxy compound
- Phenol ether
- Pyrrolidine carboxylic acid
- Pyrrolidine carboxylic acid or derivatives
- N-arylamide
- Alkyl aryl ether
- Aralkylamine
- Monocyclic benzene moiety
- Benzenoid
- N-alkylpyrrolidine
- Pyrrole
- Pyrrolidine
- Tertiary amine
- Secondary carboxylic acid amide
- Tertiary aliphatic amine
- Carboxamide group
- Amino acid
- Organoheterocyclic compound
- Azacycle
- Carboxylic acid
- Ether
- Monocarboxylic acid or derivatives
- Oxacycle
- Acetal
- Organic oxygen compound
- Organic nitrogen compound
- Carbonyl group
- Amine
- Organonitrogen compound
- Organooxygen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organic oxide
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 5.99 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 16.0694 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.03 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2711.3 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 205.0 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 246.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 180.8 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 147.4 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 712.3 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 762.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 164.8 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1364.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 660.4 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1783.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 454.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 456.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 192.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 145.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized| Metabolite | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)- | CCCOC1=CC=C(C=C1)C1C(C(CN1CC(=O)NC1=C(CC)C=CC=C1CC)C1=CC2=C(OCO2)C=C1)C(O)=O | 5224.0 | Standard polar | 33892256 | | 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)- | CCCOC1=CC=C(C=C1)C1C(C(CN1CC(=O)NC1=C(CC)C=CC=C1CC)C1=CC2=C(OCO2)C=C1)C(O)=O | 4326.3 | Standard non polar | 33892256 | | 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)- | CCCOC1=CC=C(C=C1)C1C(C(CN1CC(=O)NC1=C(CC)C=CC=C1CC)C1=CC2=C(OCO2)C=C1)C(O)=O | 4540.6 | Semi standard non polar | 33892256 |
Derivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)-,2TMS,isomer #1 | CCCOC1=CC=C(C2C(C(=O)O[Si](C)(C)C)C(C3=CC=C4OCOC4=C3)CN2CC(=O)N(C2=C(CC)C=CC=C2CC)[Si](C)(C)C)C=C1 | 4330.3 | Semi standard non polar | 33892256 | | 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)-,2TMS,isomer #1 | CCCOC1=CC=C(C2C(C(=O)O[Si](C)(C)C)C(C3=CC=C4OCOC4=C3)CN2CC(=O)N(C2=C(CC)C=CC=C2CC)[Si](C)(C)C)C=C1 | 4047.4 | Standard non polar | 33892256 | | 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)-,2TMS,isomer #1 | CCCOC1=CC=C(C2C(C(=O)O[Si](C)(C)C)C(C3=CC=C4OCOC4=C3)CN2CC(=O)N(C2=C(CC)C=CC=C2CC)[Si](C)(C)C)C=C1 | 5481.9 | Standard polar | 33892256 | | 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)-,2TBDMS,isomer #1 | CCCOC1=CC=C(C2C(C(=O)O[Si](C)(C)C(C)(C)C)C(C3=CC=C4OCOC4=C3)CN2CC(=O)N(C2=C(CC)C=CC=C2CC)[Si](C)(C)C(C)(C)C)C=C1 | 4717.4 | Semi standard non polar | 33892256 | | 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)-,2TBDMS,isomer #1 | CCCOC1=CC=C(C2C(C(=O)O[Si](C)(C)C(C)(C)C)C(C3=CC=C4OCOC4=C3)CN2CC(=O)N(C2=C(CC)C=CC=C2CC)[Si](C)(C)C(C)(C)C)C=C1 | 4413.2 | Standard non polar | 33892256 | | 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)-,2TBDMS,isomer #1 | CCCOC1=CC=C(C2C(C(=O)O[Si](C)(C)C(C)(C)C)C(C3=CC=C4OCOC4=C3)CN2CC(=O)N(C2=C(CC)C=CC=C2CC)[Si](C)(C)C(C)(C)C)C=C1 | 5535.3 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)- GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)- GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)- GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)- GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
|
|---|